National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom.

Bakhai, Ameet

National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom. [electronic resource] - International journal of cardiology Oct 2003 - 163-72 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0167-5273

10.1016/s0167-5273(03)00023-8 doi


Aged
Angina, Unstable--drug therapy
Anticoagulants--adverse effects
Cardiac Catheterization
Coronary Angiography
Coronary Disease--drug therapy
Electrocardiography--economics
Female
Hemorrhage--chemically induced
Heparin--adverse effects
Humans
Male
Middle Aged
Myocardial Infarction--drug therapy
Patient Admission
Platelet Aggregation Inhibitors--adverse effects
Platelet Glycoprotein GPIIb-IIIa Complex--adverse effects
Predictive Value of Tests
Prospective Studies
Risk Factors
Sensitivity and Specificity
Syndrome
Tirofiban
Treatment Outcome
Tyrosine--adverse effects
United Kingdom--epidemiology